Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
AM251: From CB1 Mechanism to Translation
2026-08-19
AM251 is a potent CB1 receptor antagonist that helps translational researchers separate receptor-dependent cannabinoid biology from downstream effects in pain, appetite, neuronal excitability, and cell-cycle models. This thought-leadership perspective connects recent cannabidiol findings with practical antagonist workflows and defines the evidence boundaries for moving from mechanistic experiments toward translational hypotheses.
-
Propranolol: From β-Blockade to Translation
2026-08-19
A mechanistic and strategic guide to using Propranolol in cardiovascular regulation, emotional memory modulation, essential tremor therapy, and metabolic research while improving exposure control, endpoint selection, and translational rigor.
-
Exendin-4: From Signal to Assay Design
2026-08-18
Exendin-4 (Exenatide) is more than a GLP-1 receptor agonist: it is a powerful tool for connecting cAMP signaling with beta cell phenotypes and translational assay design. This guide interprets recent yeast-expression research and shows how to build more informative, better-controlled experiments.
-
OSMI-1: O-GlcNAc Transferase Inhibitor Workflows
2026-08-18
OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor for experimentally lowering protein O-GlcNAcylation and testing pathway directionality. This guide translates its target-engagement profile into workflows for ferroptosis, trophoblast biology, and broader O-GlcNAcylation research while emphasizing dose control, orthogonal validation, and cytotoxicity boundaries.
-
Canagliflozin Hemihydrate: SGLT2 Research Guide
2026-08-17
Canagliflozin hemihydrate is a high-purity small-molecule SGLT2 inhibitor for glucose metabolism research and diabetes mellitus research. Its renal glucose reabsorption mechanism is distinct from mTOR inhibition, and a 2025 drug-sensitized yeast study found no evidence that canagliflozin inhibited TOR in that model.
-
MRT68921 ULK1 Kinase Inhibitor: Assay Guide
2026-08-17
This scenario-based guide explains how MRT68921 dual autophagy kinase ULK1/2 inhibitor, SKU B6174, can help researchers interpret viability, proliferation, and cytotoxicity assays through mechanistic autophagy inhibition. It covers formulation, controls, ATG13 phosphorylation blockade, LC3 flux measurement, energy-stress interpretation, and practical product-selection criteria.
-
Nigericin sodium salt: Practical Ionophore Workflow
2026-08-16
Nigericin sodium salt (SKU B7644) is a potassium ionophore for experimentally manipulating K+/H+ exchange, membrane ion gradients, and cytoplasmic pH. This guide covers solvent selection, short-exposure assay setup, controls, and troubleshooting; it is intended for research workflows rather than diagnostic, therapeutic, or medical use.
-
Demethyleneberberine in Reliable Cell Assays
2026-08-15
Learn how Demethyleneberberine (SKU N2087) can support better-controlled viability, proliferation, senescence, and inflammatory cell assays. This scenario-based guide connects concentration selection, solvent handling, orthogonal validation, and vendor evaluation to published NSCLC findings and documented product specifications.
-
Dextrose in Hypoxia-Driven Immunometabolism
2026-08-14
Dextrose (D-glucose) is more than a routine culture additive: it is a controllable input for dissecting glucose competition, hypoxia adaptation, and immune-cell function. This guide translates recent tumor-microenvironment insights into rigorous assay-design and handling decisions.
-
Omeprazole (A2845) Protocol and QC Guide
2026-08-14
Omeprazole (SKU A2845) provides a research tool for controlled studies of H+,K+-ATPase activity and gastric acid secretion, including antiulcer activity studies and peptic ulcer disease models. It is insoluble in water and ethanol, requires DMSO-based preparation, and is intended only for scientific research—not diagnostic, clinical, or medical use.
-
6-FAM SE: Designing Durable Molecular Readouts
2026-08-13
6-FAM SE enables stable amine-directed fluorescent labeling across sequencing, nucleotide, protein, and peptide workflows. This guide presents a measurement-focused framework for selecting, validating, and interpreting fluorescent conjugates, with a critical comparison to modular nanomedicine design.
-
FOXM1 Autophagic Degradation and Chemoresistance
2026-08-13
The reference study identified STL427944 through gene network analysis and showed that it suppresses the oncogenic transcription factor FOXM1 by moving it from the nucleus to the cytoplasm for autophagic degradation. This mechanism selectively reduced FOXM1-related transcriptional programs and sensitized human cancer cells to platinum drugs, 5-fluorouracil, and taxanes, providing a mechanistic framework for overcoming chemotherapy resistance.
-
Ertugliflozin (PF-04971729) Research Workflows
2026-08-12
Ertugliflozin (PF-04971729) combines highly selective SGLT2 biology with a practical workflow for renal glucose transport, diabetes mellitus research, and exploratory brain insulin-signaling studies. This guide translates the reference rat study into assay-ready steps, controls, and troubleshooting decisions without overstating clinical or central nervous system evidence.
-
(R,S)-Anatabine for Reliable Cell Assays
2026-08-12
This scenario-based guide explains how SKU C4859, (R,S)-Anatabine, can be incorporated into cell viability, proliferation, and amyloid-processing workflows without confusing pathway activity with nonspecific cytotoxicity. It covers model selection, solvent control, protocol preparation, data interpretation, and practical supplier evaluation.
-
CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness
2026-08-11
Boyle et al. showed that CCR7 and Notch1 form a functional signaling circuit that sustains stem-like properties in MMTV-PyMT mammary cancer cells. The work provides a mechanistic basis for considering coordinated disruption of both axes, while its primary-cell mouse model also defines important limits for clinical translation.